SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-296245
Filing Date
2021-10-12
Accepted
2021-10-12 06:17:57
Documents
16
Period of Report
2021-10-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d240073d8k.htm   iXBRL 8-K 31333
2 EX-10.1 d240073dex101.htm EX-10.1 32020
3 EX-99.1 d240073dex991.htm EX-99.1 7965
7 GRAPHIC g240073g1008221414921.jpg GRAPHIC 3726
8 GRAPHIC g240073g1011231441249.jpg GRAPHIC 3704
  Complete submission text file 0001193125-21-296245.txt   218432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20211005.xsd EX-101.SCH 2905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20211005_lab.xml EX-101.LAB 17375
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20211005_pre.xml EX-101.PRE 10962
9 EXTRACTED XBRL INSTANCE DOCUMENT d240073d8k_htm.xml XML 3231
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 211316736
SIC: 2834 Pharmaceutical Preparations